Justice Department targets another Bay Area drug maker’s sponsored testing program

In the case of another Bay Area drug maker, the DoJ looked at company-sponsored genetic testing program as a form of kickback.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks